Related Experiment Video
Updated: Jan 21, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial
Amit Kaura1,2, Laszlo Sztriha3, Fong Kum Chan3
1King's College London NHS Foundation Trust, King's College Hospital, Denmark Hill, London, SE5 9RS, UK. amit.kaura@nhs.net.
Insights
A 14-day ECG patch detected significantly more cases of paroxysmal atrial fibrillation (PAF) than Holter monitors after stroke or TIA. This prolonged monitoring is more effective and cost-effective for preventing future strokes.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Cardioembolism from paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischemic attack (TIA) or ischemic stroke.
- Short-duration Holter monitoring may miss a significant proportion of PAF events due to their transient nature.
Purpose of the Study:
- To compare the diagnostic yield of a 14-day ECG monitoring patch versus short-duration Holter monitoring for detecting PAF in patients who have experienced a TIA or ischemic stroke.
- To assess the cost-effectiveness of patch-based monitoring for preventing recurrent strokes.
Main Methods:
- An open-label randomized controlled trial comparing a 14-day ECG monitoring patch (Zio® Patch) with short-duration Holter monitoring.
- Primary outcome: detection of ECG-documented PAF (≥30 seconds) within 90 days.
- Included a budget impact analysis from a healthcare perspective.
Main Results:
- The 14-day patch detected PAF in 16.3% of patients, compared to 2.1% with Holter monitoring (Odds Ratio 8.9, P=0.026).
- Successful monitor placement was high in both groups (76.8% patch vs. 78.3% Holter).
- The patch-based approach was projected to avoid 10.8 strokes annually and save over £113,000 in direct medical costs.
Conclusions:
- Early, prolonged, patch-based monitoring is superior to short-duration Holter monitoring for detecting PAF after stroke or TIA.
- Patch-based monitoring is likely cost-effective for preventing recurrent strokes.
- The Zio® Patch demonstrated higher diagnostic yield and potential for significant healthcare cost savings.
Background:
Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events.
Methods:
We conducted an open-label randomised controlled trial of cardiac monitoring after a TIA or ischaemic stroke comparing a 14-day ECG monitoring patch (Zio® Patch, iRhythm Technologies) with short-duration Holter monitoring for the detection of PAF. The primary outcome was the detection of one or more episodes of ECG-documented PAF lasting at least 30 s within 90 days in each of the study arms. A budget impact analysis from the healthcare perspective was performed.
Results:
From February 2016 through February 2017, 43 (76.8%) of the 56 patients assigned to the patch-based monitoring group and 47 (78.3%) of the 60 patients assigned to short-duration Holter monitoring group had successful monitor placement with 90 days of follow-up. Of the 26 protocol failures between the two groups, 23 (88.5%) were due to patient refusal for outpatient short-duration ECG monitor placement, whilst only 1 (3.8%) was due unsuccessful ZioPatch placement. The rate of detection of PAF at 90 days was 16.3% in the patch-based monitoring group (seven patients) compared to 2.1% in the short-duration Holter monitoring group (1 patient), with an odds ratio of 8.9 (95% CI 1.1-76.0; P = 0.026). An economic model demonstrated that implementation of the Zio Patch service would result in 10.8 more strokes avoided per year compared to current practice with Holter monitoring with an associated yearly saving in direct medical costs of £113,630, increasing to £162,491 over 5 years.
Conclusions:
Early, prolonged, patch-based monitoring after an index stroke or TIA is superior to short-duration Holter monitoring in the detection of PAF and likely cost-effective for preventing recurrent strokes. Trial registration http://www.isrctn.com. Unique identifier: ISRCTN 50253271. Registered 21 January 2016.
Related Concept Videos
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Trial and Error and Algorithm
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...

